Virbac SA engages in the manufacture and sale of veterinary medicines. The company is headquartered in Carros, Paca and currently employs 5,620 full-time employees. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. The company also offers food and electronic identification chips for pets.
Follow-Up Questions
VRBCF 주식의 가격 성능은 어떻습니까?
VRBCF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Virbac SA의 주요 사업 주제나 업종은 무엇입니까?
Virbac SA은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
Virbac SA의 시가총액은 얼마입니까?
Virbac SA의 현재 시가총액은 $0입니다
Virbac SA는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 12명의 분석가가 Virbac SA에 대한 분석 평가를 실시했으며, 이는 4명의 강력한 매수, 7명의 매수, 3명의 보유, 0명의 매도, 그리고 4명의 강력한 매도를 포함합니다
